MedTrace Logo

Comparison Between Point of Care Device and Venous Blood International Normalized Ratio Measurements.

NCT00288808 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2015-04-27

No results posted yet for this study

Summary

Investigate the validity of Hemosense System in pediatric patients on anticoagulation therapy.

Conditions

  • Blood Coagulation Disorder

Interventions

DEVICE

Hemosense (PT/InR point of care device)

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Peter H Chang, D.O. · University of Rochester Strong Memorial Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00288808 on ClinicalTrials.gov